PBE vs. HELX ETF Comparison

Comparison of PowerShares Dynamic Biotech & Genome (PBE) to Franklin Genomic Advancements ETF (HELX)
PBE

PowerShares Dynamic Biotech & Genome

PBE Description

The PowerShares Dynamic Biotechnology & Genome Portfolio (Fund) is based on the Dynamic Biotech & Genome IntellidexSM Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances biotechnology and genetic engineering and reseach. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.

Grade (RS Rating)

Last Trade

$75.54

Average Daily Volume

8,623

Number of Holdings *

30

* may have additional holdings in another (foreign) market
HELX

Franklin Genomic Advancements ETF

HELX Description Seeks capital appreciation by investing in innovative companies related to genomic-based technologies designed to enhance the quality of life. Provides access to companies benefitting from or facilitating the use of new research including DNA sequencing, gene editing and personalized medicine Uses bottom-up fundamental research conducted by dedicated, industry-specific analysts to identify disruptive business models at the right stage for investment Actively managed by a seasoned portfolio management team that is based in Silicon Valley and has a long history of investing in the craft of innovation

Grade (RS Rating)

Last Trade

$45.60

Average Daily Volume

5,551

Number of Holdings *

44

* may have additional holdings in another (foreign) market
Performance
PBE HELX
30 Days 0.92%
60 Days -7.89%
90 Days -0.79%
12 Months 54.09%
7 Overlapping Holdings
Grade Symbol Weight in PBE Weight in HELX Overlap
C CTLT 4.86% 3.09% 3.09%
D ILMN 4.6% 4.78% 4.6%
C NTLA 3.52% 5.96% 3.52%
D PACB 2.98% 2.58% 2.58%
C QGEN 5.19% 0.79% 0.79%
B TECH 5.64% 0.97% 0.97%
D VCYT 2.52% 1.05% 1.05%
PBE Overweight 23 Positions Relative to HELX
Grade Symbol Weight
B AMGN 5.51%
B ALXN 5.11%
F SGEN 4.89%
F BMRN 4.86%
B FPRX 4.55%
B VCEL 3.48%
B UTHR 3.29%
B IRWD 3.17%
F SGMO 2.79%
D ALKS 2.71%
D BPMC 2.71%
F OPK 2.68%
D MYGN 2.61%
B DRNA 2.59%
C CDNA 2.55%
C HALO 2.47%
D XNCR 2.47%
D PGEN 2.36%
D FLGT 2.3%
F EBS 2.24%
D ARWR 2.15%
D MNKD 2.13%
F FGEN 1.05%
PBE Underweight 37 Positions Relative to HELX
Grade Symbol Weight
B RGEN -5.06%
D NTRA -4.76%
D CRSP -3.98%
B GH -3.31%
B TXG -3.27%
C VEEV -3.05%
F TDOC -2.74%
B TMO -2.71%
A CRL -2.49%
A BNTX -2.43%
F NVTA -2.1%
B A -2.1%
C MRNA -2.03%
D EXAS -1.98%
D CYRX -1.76%
D FATE -1.75%
B BRKR -1.68%
A PRAH -1.63%
B MEDP -1.53%
B NSTG -1.49%
D NEO -1.46%
D RCKT -1.3%
F EDIT -1.13%
A NVDA -1.12%
D BEAM -1.07%
A PPD -1.01%
F IOVA -0.99%
C PKI -0.94%
C TWST -0.91%
B BRKS -0.85%
B BIO -0.8%
B ICLR -0.6%
D LGND -0.52%
F RARE -0.52%
F BLI -0.49%
F AMWL -0.48%
F PTCT -0.37%
Compare ETFs